These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27438692)

  • 1. Gastrointestinal perforation during regorafenib administration in a case with hepatic metastases of colon cancer.
    Ogata K; Takamori H; Umezaki N; Yagi T; Ogawa K; Ozaki N; Hayashi H; Tanaka H; Ikuta Y; Doi K
    J Chemother; 2017 Oct; 29(5):314-316. PubMed ID: 27438692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Perforation in a Patient with Colon Cancer during Treatment with Regorafenib: A Case Report and Review of the Literature.
    Ouchi R; Okada K; Usui K; Kurata N; Suzuki S; Nagao M; Watanabe Y; Koyama K
    Tohoku J Exp Med; 2021 Jul; 254(3):207-211. PubMed ID: 34321384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regorafenib use as a possible cause of intestinal perforation.
    Adenis A; Kotecki N; Decanter G; Clisant S; Penel N
    Acta Oncol; 2013 Nov; 52(8):1789-90. PubMed ID: 24024697
    [No Abstract]   [Full Text] [Related]  

  • 4. Intestinal perforation after regorafenib usage.
    Sarıcı B; Karakaş S; Uylas U; Aktaş A; Dikilitaş M; Kayaalp C
    Turk J Gastroenterol; 2018 Mar; 29(2):245-247. PubMed ID: 29749339
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of erythema multiforme induced by regorafenib therapy for metastatic colon cancer].
    Mii Y; Fukuoka E; Murata K; Otsubo D; Sawa H; Oka S; Iwatani Y; Kuroda D
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1841-3. PubMed ID: 25731348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiological complete response with regorafenib for multiple lung metastases of ascending colon cancer: a case report.
    Kikuchi K; Ogawa M; Sasaki A
    J Med Case Rep; 2024 Feb; 18(1):45. PubMed ID: 38321556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two Episodes of Colostomy-Associated Intestinal Perforation during Chemotherapy for Metastatic Rectal Cancer].
    Tamura H; Otani A; Tsukui M; Toge K; Otani T; Hirose Y; Morimoto Y; Yoshino K; Kido T; Endo K; Kameyama H; Kobayashi T; Wakai T
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2172-2174. PubMed ID: 28133259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful Administration of Regorafenib to a Metastatic Colon Cancer Patient with Impaired Performance Status by Reducing the Initial Dose].
    Nishitai R; Manaka D; Kudo R; Mitsuoka E; Kanai S; Kanto S; Yoshino K; Hamasu SY; Konishi S; Yamashiro Y
    Gan To Kagaku Ryoho; 2015 Jul; 42(7):871-3. PubMed ID: 26197753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two Cases of Bowel Perforation during Chemotherapy with Bevacizumab to Metastatic Rectal Cancer].
    Miyake Y; Ikeda K; Murakami M; Oka Y; Nezu R; Kurokawa E; Kikkawa N
    Gan To Kagaku Ryoho; 2015 Dec; 42 Suppl 1():75-8. PubMed ID: 26809419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of diffuse infiltrating carcinoma of large intestine with liver metastases effectively treated with systemic chemotherapy].
    Murahashi K; Takagaki K; Kishimoto K; Mino A; Nishino K; Aoki T; Sowa M
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):673-6. PubMed ID: 21499003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of delayed colonic perforation after metallic stent placement for advanced descending colon cancer during bevacizumab-based chemotherapy].
    Tanaka I; Hisai H; Miyazaki E; Ono M; Maeda Y; Sato M; Kawasaki R; Gyobu H; Nakajima S; Yamada S; Muramatsu H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2319-21. PubMed ID: 22202368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Patient with Cavitated Pulmonary Metastases Treated with Regorafenib].
    Taniguchi M; Mori M; Sata N; Fujii H
    Gan To Kagaku Ryoho; 2016 Jun; 43(6):757-9. PubMed ID: 27306815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Liver Failure Due to Regorafenib May Be Caused by Impaired Liver Blood Flow: A Case Report.
    Akamine T; Ando K; Oki E; Saeki H; Nakashima Y; Imamura YU; Ohgaki K; Maehara Y
    Anticancer Res; 2015 Jul; 35(7):4037-41. PubMed ID: 26124352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose regorafenib-induced hypertensive crisis.
    Yilmaz B; Kemal Y; Teker F; Kut E; Demirag G; Yucel I
    Exp Oncol; 2014 Jun; 36(2):134-5. PubMed ID: 24980770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-Term Survival of a Patient with Metastatic Liver and Para-Aortic Lymph Node Cancer from Colon Cancer Treated with Regorafenib].
    Watanabe N; Akagi S; Inoue H; Nakatsuji H; Ito H; Toma A; Nakamura K; Ochiai T; Otsuji E
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1732-1734. PubMed ID: 29394758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial.
    Argilés G; Saunders MP; Rivera F; Sobrero A; Benson A; Guillén Ponce C; Cascinu S; Van Cutsem E; Macpherson IR; Strumberg D; Köhne CH; Zalcberg J; Wagner A; Luigi Garosi V; Grunert J; Tabernero J; Ciardiello F
    Eur J Cancer; 2015 May; 51(8):942-9. PubMed ID: 25818084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral sensorineural hearing loss induced by regorafenib.
    Cheng J; Wang L; Zhu LN; Wang L
    J Clin Pharm Ther; 2019 Dec; 44(6):963-965. PubMed ID: 31381817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells.
    Yoshii Y; Furukawa T; Aoyama H; Adachi N; Zhang MR; Wakizaka H; Fujibayashi Y; Saga T
    Int J Oncol; 2016 Apr; 48(4):1477-84. PubMed ID: 26820693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study.
    Bruix J; Tak WY; Gasbarrini A; Santoro A; Colombo M; Lim HY; Mazzaferro V; Wiest R; Reig M; Wagner A; Bolondi L
    Eur J Cancer; 2013 Nov; 49(16):3412-9. PubMed ID: 23809766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of metachronous gastrointestinal perforation of a patient with metastatic rectal cancer during treatment with bevacizumab-based chemotherapy].
    Sadatomo A; Koinuma K; Miki A; Horie H; Yasuda Y
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):943-5. PubMed ID: 23863742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.